Loading clinical trials...

Quality of Life in Pediatric Participants With HHT | Clinical Trials | Clareo Health

Not Yet RecruitingNCT07474428

Quality of Life in Pediatric Participants With HHT

This observational study evaluates health-related quality of life (HR-QoL) in pediatric and young adult patients aged 2-25 years with Hereditary Hemorrhagic Telangiectasia (HHT). Eligible participants...

Lead sponsor: Ashley Nelson•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Katie Wusik, Master of Genetic Counseling

CONTACT

(513) 636-3200 [email protected]

Ashley Nelson

CONTACT

[email protected]

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment70

Start dateJul 2026

Last updatedMar 16, 2026

Condition

Hereditary Haemorrhagic Telangiectasia (HHT)

Locations shown

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 16, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions